Literature DB >> 17257582

The active zone protein CAST directly associates with Ligand-of-Numb protein X.

Susumu Higa1, Takashi Tokoro, Eiji Inoue, Isao Kitajima, Toshihisa Ohtsuka.   

Abstract

The presynaptic active zone (AZ) is a specialized site where neurotransmitter release occurs in a precisely regulated manner. The cytomatrix at the AZ (CAZ)-associated protein CAST and its family member ELKS form a large molecular complex at the AZ and regulate neurotransmitter release by binding other AZ proteins including Bassoon, Piccolo, Munc13-1, and RIM1. Here, yeast two-hybrid screening was used to identify Ligand-of-Numb Protein X (LNX) as a potential binding partner for CAST. LNX is an interactor of Numb and has four PDZ domains. CAST bound LNX both in vivo and in vitro. This binding required the COOH-terminus of CAST and the second PDZ domain of LNX. CAST and LNX were further colocalized with each other in a heterologous expression system, in which LNX was recruited to a Triton X-insoluble structure. Moreover, exogenously expressed LNX was partially colocalized with endogenous CAST in the axonal varicosities of cultured rat hippocampal neurons. These results suggest that CAST and LNX might form a protein complex in neurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17257582     DOI: 10.1016/j.bbrc.2007.01.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  LNX (Ligand of Numb-protein X) interacts with RhoC, both of which regulate AP-1-mediated transcriptional activation.

Authors:  Dan Zheng; Yaqiong Sun; Shaohua Gu; Chaoneng Ji; Wei Zhao; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2009-08-23       Impact factor: 2.316

2.  Decreased Anxiety-Related Behaviour but Apparently Unperturbed NUMB Function in Ligand of NUMB Protein-X (LNX) 1/2 Double Knockout Mice.

Authors:  Joan A Lenihan; Orthis Saha; Victoria Heimer-McGinn; John F Cryan; Guoping Feng; Paul W Young
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

3.  Age-associated changes in synaptic lipid raft proteins revealed by two-dimensional fluorescence difference gel electrophoresis.

Authors:  Lei Jiang; Jianwen Fang; David S Moore; Natalia V Gogichaeva; Nadezhda A Galeva; Mary L Michaelis; Asma Zaidi
Journal:  Neurobiol Aging       Date:  2008-12-31       Impact factor: 4.673

4.  Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes.

Authors:  Kenneth Andrew Ross
Journal:  BMC Med       Date:  2011-02-03       Impact factor: 8.775

5.  Molecular evolution of the LNX gene family.

Authors:  Michael Flynn; Orthis Saha; Paul Young
Journal:  BMC Evol Biol       Date:  2011-08-09       Impact factor: 3.260

6.  Biochemical and computational analysis of LNX1 interacting proteins.

Authors:  Cheryl D Wolting; Emily K Griffiths; Renu Sarao; Brittany C Prevost; Leanne E Wybenga-Groot; C Jane McGlade
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

7.  Proteomic analysis reveals novel ligands and substrates for LNX1 E3 ubiquitin ligase.

Authors:  Joan A Lenihan; Orthis Saha; Paul W Young
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

Review 8.  LNX1/LNX2 proteins: functions in neuronal signalling and beyond.

Authors:  Paul W Young
Journal:  Neuronal Signal       Date:  2018-06-07

9.  Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.

Authors:  Lin Ma; Lan Wang; Yating Shan; Muhammad Nafees; Elshoura Ihab; Ruhui Zhang; Fangjun Wang; Wu Yin
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2.

Authors:  A de la Rocha-Muñoz; E Núñez; E Arribas-González; B López-Corcuera; C Aragón; J de Juan-Sanz
Journal:  Sci Rep       Date:  2019-10-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.